Related Experiment Video
Updated: Jul 3, 2026

Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry
Published on: April 6, 2022
The effects of aging, injury and disease on microglial function: a case for cellular senescence
Kelly R Miller1, Wolfgang J Streit
1Department of Neuroscience, University of Florida College of Medicine, McKnight Brain Institute, Florida, USA.
Abstract:
Neuroinflammation resulting from chronic reactive microgliosis is thought to contribute to age-related neurodegeneration, as well as age-related neurodegenerative diseases, specifically Alzheimer's disease (AD). Support of this theory comes from studies reporting a progressive, age-associated increase in microglia with an activated phenotype. Although the underlying cause(s) of this microglial reactivity is idiopathic, an accepted therapeutic strategy for the treatment of AD is inhibition of microglial activation using anti-inflammatory agents. Although the effectiveness of anti-inflammatory treatment for AD remains equivocal, microglial inhibition is being tested as a potential treatment for additional neurodegenerative disorders including amyotrophic lateral sclerosis and Parkinson's disease. Given the important and necessary functions of microglia in normal brain, careful evaluation of microglial function in the aged brain is a necessary first step in targeting more precise treatment strategies for aging-related neurodegenerative diseases. Studies from our laboratory have shown multiple age-related changes in microglial morphology and function that are suggestive of cellular senescence. In this manuscript, we review current knowledge of microglia in the aging brain and present new, unpublished work that further supports the theory that microglia experience an age-related decline in proliferative function as a result of cellular senescence.
Insights
Microglia, the brain's immune cells, show signs of aging and reduced function, potentially contributing to neurodegeneration. This cellular senescence in microglia may impact treatments for Alzheimer's disease and other brain disorders.
Area of Science:
- Neuroscience
- Immunology
- Cellular Biology
Background:
- Chronic microglial activation (microgliosis) is linked to age-related neurodegeneration and Alzheimer's disease (AD).
- Microglia play crucial roles in brain health, necessitating a thorough understanding of their function in aging.
- Current AD treatments targeting microglial activation have shown mixed results, prompting further investigation.
Purpose of the Study:
- To review current knowledge on microglia in the aging brain.
- To present new findings suggesting age-related decline in microglial proliferative function due to cellular senescence.
- To evaluate microglial function in the aged brain for improved therapeutic strategies.
Main Methods:
- Review of existing literature on microglia and aging.
- Presentation of unpublished experimental data on microglial morphology and function in aged models.
- Analysis of cellular senescence markers in aged microglia.
Main Results:
- Evidence suggests age-related changes in microglial morphology and function.
- New data indicate a decline in microglial proliferative capacity associated with cellular senescence.
- These findings support the hypothesis of microglial aging contributing to neurodegeneration.
Conclusions:
- Microglia undergo age-related changes, including cellular senescence.
- This senescence may impair their normal functions and contribute to neurodegenerative diseases.
- Targeting microglial senescence could offer novel therapeutic avenues for age-related brain disorders.
More Related Videos
Related Concept Videos
The Effect of Aging on Tissues
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Mitochondria
Cellular Injury V: Apoptosis and Autophagy
Cellular Injury I: Introduction
Cellular Injury IlI: Cellular Death

